BBB National Programs Decision Summaries

BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.

 

For the full text of NAD, NARB, and CARU decisions, subscribe to the Online Archive. Other case decisions are available publicly: DSSRC and DAAP. For members of the press, the full text of any BBB National Programs decision is available by emailing the request to press@bbbnp.org.
  • All

  • 6/29/2020 - Social Media Post Implying Continual-G Glutathione Enhancer Protects Against COVID-19 is Discontinued Following NAD Inquiry

    Following an inquiry by the National Advertising Division (NAD), INID Research Lab, LLC discontinued a social media post that conveyed an implied message that the immunity-boosting capabilities of Continual-G Glutathione Enhancer protect consumers against COVID-19. The challenged social media post showed an image of a woman wearing a face mask with the text, “Strong IMMUNITY Needs Glutathione” and associated text stating “Building your immunity during these times is more important than ever.” 

  • 6/26/2020 - NAD Finds T-Mobile Pricing Claim Not Misleading; Recommends Modifications to Certain Disclosures for Unlimited Wireless Plans

    The National Advertising Division (NAD) determined that T-Mobile USA, Inc.’s “four lines” advertising was not misleading as to the price per line of a wireless plan. However, NAD recommended modification of disclosures to advertising for T-Mobile’s Essentials and other unlimited plan offerings in certain contexts, to clearly and conspicuously disclose why and when Essentials plan customers will experience prioritization lower than other T-Mobile customers. T-Mobile’s claims were challenged by Charter Communications, Inc., provider of a competing wireless service. 

  • 6/26/2020 - Advertiser Agrees to Refrain from Claims that Provezza Elderberry Syrup Protects Against COVID-19

    Provezza Health, LLC informed the National Advertising Division (NAD) that, prior to the opening of NAD’s inquiry, it had permanently discontinued the Instagram post of Provezza Elderberry Syrup with the text, “Potent Immune Support During A Severe Season” and associated text stating “Provezza is highly concentrated to deliver antioxidant action for immune defense” because the advertisement’s publication cycle had ended. While the advertiser disagreed that the post challenged by NAD conveyed the implied claim that Provezza Elderberry Syrup protects users against COVID-19, it committed to refrain from making express or implied claims with such a message in the future.

  • 6/18/2020 - Privacy Watchdog Brings Luxury Eyewear Maker and Online Insurance Marketplace into Digital Advertising Compliance

    BBB National Programs’ Digital Advertising Accountability Program (DAAP) today released two new data privacy cases for Luxottica and Compare.com issuing recommendations and outlining actions taken to date to bring these companies into compliance with the Digital Advertising Alliance’s (DAA) Self-Regulatory Principles (DAA Principles). 

  • 6/17/2020 - NAD Refers Ceres Turf, Inc. Advertising Claims to FTC After Advertiser Declines to Participate

    The National Advertising Division (NAD) has referred advertising claims made by Ceres Turf, Inc. to the Federal Trade Commission (FTC) for further review after the company declined to participate in a proceeding before NAD. 

     

  • 6/16/2020 - P&G Will Appeal NAD’s Recommendation to Discontinue Use of #1 Claim for Oral-B Interdental Picks

    The National Advertising Division (NAD) recommended that the Procter & Gamble Company (P&G) discontinue a “#1” claim in its advertising for Oral-B interdental picks. This claim, which appeared on product packaging, free-standing inserts, and online point of purchase advertising and product descriptions was challenged by Sunstar Americas, Inc. (Sunstar), manufacturer of the competing brand of GUM interdental picks. P&G said it will appeal this adverse finding to the National Advertising Review Board. 

  • 6/11/2020 - NAD Recommends Discontinuance of Blood Boost Dietary Supplement Claim to “Cure” Type 2 Diabetes and “Reverse” Insulin Resistance

    The National Advertising Division (NAD) recommended that Nature’s Boost, LLC discontinue certain health-related efficacy claims concerning the ability of its Blood Boost Formula dietary supplement to cure diabetes or substantially reduce a diabetic’s symptoms. NAD further recommended that the advertiser discontinue qualified claims as to the efficacy of any Blood Boost ingredient to confer these benefits, as well as a claim that the product is “all-natural.” The claims were challenged by the Council for Responsible Nutrition (CRN). 

  • 6/10/2020 - First Three NAD Fast-Track SWIFT Cases Resolved by Government Agency Referral, Modified Claim, and Administrative Closure

    Within one month of BBB National Programs’ National Advertising Division (NAD) launching the NAD Fast-Track SWIFT (Single Well-Defined Issue Fast Track) challenge process earlier this spring, the goal was initiation to decision in 20 business days. 

  • 6/10/2020 - NAD Recommends Discontinuance of Certain “Natural” Claims for Air Wick Essential Mist and Scented Oils; Finds “Lasts up to 60 days” Claim Supported

    The National Advertising Division (NAD) recommended that Reckitt Benckiser discontinue certain challenged “natural” claims for Air Wick Fragrance Essential Mist and Air Wick Scented Oils, but determined that the advertiser’s durational claim that Scented Oils “lasts up to 60 days” was substantiated. The claims were challenged by S.C. Johnson & Son, Inc., manufacturer of the competing Glade brand of home fragrance products.  

  • 6/09/2020 - NAD Recommends Fillerina Skincare Products Discontinue Certain Product Performance Claims

    Following an inquiry by the National Advertising Division (NAD), initiated as part of its routine monitoring program, NAD determined that Qf Systems, LLC did not substantiate certain express and implied claims for Fillerina Dermo-Cosmetic Replenishing Gel and Nourishing Film. Therefore, NAD recommended that the advertiser discontinue the claims “Boosted with a powerful blend of hyaluronic acids, this at-home skin care treatment fills in fine lines and wrinkles, revealing a more radiant complexion,” “Fillerina Dermo-Cosmetic Filler Treatment Grade 2 corrects visible wrinkles and expression lines” (and similar express claims) and the implied claim that Fillerina removes lines and wrinkles similar to cosmetic procedures.